D-1875-2019 Class II Terminated

Recalled by AVKARE Inc. — Pulaski, TN

FDA drug recall D-1875-2019 was initiated by AVKARE Inc. on Aug 28, 2019 and is designated Class II. Reason for recall: Failed Stability Specifications. The recall status is terminated (terminated Oct 27, 2021). Affected quantity: 5953 bottles.

Recall details

Product Type
Drugs
Report Date
Sep 18, 2019
Initiation Date
Aug 28, 2019
Termination Date
Oct 27, 2021
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
5953 bottles

Product description

AVKARE Fexofenadine Hydrochloride Tablets USP Antihistamine 180 mg, 500 Tablets per bottle, NDC 42291-297-50.

Reason for recall

Failed Stability Specifications.

Distribution pattern

Nationwide in the U.S.

Code information

Lot #s: 067180011A; 067180012A, Exp. 04/2021; 06718027B1 Exp. 09/2021

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-1875-2019
openFDA file date
Nov 10, 2026
Loaded by RegDataLab
Nov 11, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-1875-2019. Report a data issue: hello@regdatalab.com.